A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to PaclitaxelJinhua Zhou, Robert C. Bast, Albandri Alfraidi et al.|Clinical Cancer Research|2016Cited by 77
Supplementary data from A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to PaclitaxelJinhua Zhou, Robert C. Bast, Albandri Alfraidi et al.|Unknown|2023Cited by 0
Supplementary table from A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to PaclitaxelJinhua Zhou, Robert C. Bast, Albandri Alfraidi et al.|Unknown|2023Cited by 0
Supplementary data from A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to PaclitaxelJinhua Zhou, Robert C. Bast, Albandri Alfraidi et al.|Unknown|2023Cited by 0
Supplementary table from A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to PaclitaxelJinhua Zhou, Robert C. Bast, Albandri Alfraidi et al.|Unknown|2023Cited by 0